Dashboard
1
With a growth in Net Profit of 326.49%, the company declared Outstanding results in Jun 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 225.99 MM
- ROCE(HY) Highest at 3.18%
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
2
With ROE of 1.62%, it has a very attractive valuation with a 2.85 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
CNY 1,772 Million (Small Cap)
176.00
NA
0.00%
2.39
1.62%
1.12
Revenue and Profits:
Net Sales:
398 Million
(Quarterly Results - Jun 2026)
Net Profit:
42 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.71%
0%
-4.71%
6 Months
19.52%
0%
19.52%
1 Year
-11.4%
0%
-11.4%
2 Years
28.28%
0%
28.28%
3 Years
-15.67%
0%
-15.67%
4 Years
4.9%
0%
4.9%
5 Years
0%
0%
0.0%
Liaoning Dingjide Petrochemical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.33%
EBIT Growth (5y)
-29.39%
EBIT to Interest (avg)
28.85
Debt to EBITDA (avg)
18.69
Net Debt to Equity (avg)
1.49
Sales to Capital Employed (avg)
0.26
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
41.22%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.98%
ROE (avg)
6.14%
Valuation key factors
Factor
Value
P/E Ratio
176
Industry P/E
Price to Book Value
2.85
EV to EBIT
225.52
EV to EBITDA
77.23
EV to Capital Employed
1.55
EV to Sales
8.80
PEG Ratio
0.86
Dividend Yield
NA
ROCE (Latest)
0.69%
ROE (Latest)
1.62%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
398.30
238.90
66.72%
Operating Profit (PBDIT) excl Other Income
77.80
31.70
145.43%
Interest
3.80
4.90
-22.45%
Exceptional Items
0.00
0.00
Consolidate Net Profit
42.20
6.40
559.37%
Operating Profit Margin (Excl OI)
128.20%
55.00%
7.32%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 66.72% vs 28.65% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 559.37% vs 1,700.00% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
838.60
777.70
7.83%
Operating Profit (PBDIT) excl Other Income
105.70
51.50
105.24%
Interest
18.40
12.60
46.03%
Exceptional Items
-0.40
0.00
Consolidate Net Profit
11.70
-16.80
169.64%
Operating Profit Margin (Excl OI)
19.50%
-20.70%
4.02%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 7.83% vs 2.95% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 169.64% vs -127.36% in Dec 2024
About Liaoning Dingjide Petrochemical Co., Ltd. 
Liaoning Dingjide Petrochemical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






